This inventor holds 1 USPTO granted patent. Top assignee: Other. Active years: 1980.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 834,513 Years Active: 1980
Title: Angela M Brodie: Innovator in Estrogen Biosynthesis Inhibition
Introduction
Angela M Brodie is a prominent inventor based in Fulton, MD (US). She has made significant contributions to the field of biochemistry, particularly in the development of innovative methods for inhibiting estrogen biosynthesis. Her work has implications for various medical applications, especially in hormone-related therapies.
Latest Patents
Angela M Brodie holds a patent for "Ester derivatives of 4-hydroxy-4-androstene-3,17-dione and a method for." This invention relates to ester derivatives of 4-hydroxy-4-androstene-3,17-dione (4-OH-4-A), including the acetate, heptanoate, dodecanoate, hemisuccinate, and benzoate esters of 4-OH-4-A. The patent also describes a method of using these esters in the inhibition of estrogen biosynthesis.
Career Highlights
Throughout her career, Angela has focused on advancing the understanding of steroid hormones and their derivatives. Her research has led to breakthroughs that enhance therapeutic options for conditions influenced by estrogen levels.
Collaborations
Angela has collaborated with notable colleagues, including Harry J Brodie and David Allen Marsh. These partnerships have fostered a collaborative environment that promotes innovation and research excellence.
Conclusion
Angela M Brodie's contributions to the field of biochemistry, particularly in estrogen biosynthesis inhibition, highlight her role as a leading inventor. Her innovative work continues to influence medical research and therapeutic development.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile